Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
暂无分享,去创建一个
F. Bosch | R. Foà | S. Robson | K. Trunzer | S. Stilgenbauer | V. Leblond | A. Cortelezzi | W. Knauf | S. Böttcher | M. Tiab | E. Gresko | E. Tausch | M. Turgut | A. Zaritskey | G. Cantin | J. Mérot